PL433887A1 - RoMoLab mobile automated laboratory, in particular for testing for COVID-I9 - Google Patents
RoMoLab mobile automated laboratory, in particular for testing for COVID-I9Info
- Publication number
- PL433887A1 PL433887A1 PL433887A PL43388720A PL433887A1 PL 433887 A1 PL433887 A1 PL 433887A1 PL 433887 A PL433887 A PL 433887A PL 43388720 A PL43388720 A PL 43388720A PL 433887 A1 PL433887 A1 PL 433887A1
- Authority
- PL
- Poland
- Prior art keywords
- space
- patient
- container
- spaces
- laboratory
- Prior art date
Links
- 238000012360 testing method Methods 0.000 title abstract 3
- 238000005070 sampling Methods 0.000 abstract 3
- 239000000463 material Substances 0.000 abstract 2
- 101100407148 Arabidopsis thaliana PBL3 gene Proteins 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000025721 COVID-19 Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 238000004891 communication Methods 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000005611 electricity Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 238000011160 research Methods 0.000 abstract 1
- 239000010865 sewage Substances 0.000 abstract 1
- 238000012795 verification Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Przedmiotem zgłoszenia jest mobilne automatyczne laboratorium RoMoLab zwłaszcza do testowania na COVID-19 wykorzystujące kontener, agregat prądotwórczy, monitor, panele fotowoltaiczne, sprzęt medyczny charakteryzuje się tym, że laboratorium zbudowane jest na bazie kontenera, korzystnie 40 —stopowego kontenera, przy czym kontener (K) podzielony jest wewnątrz na co najmniej trzy połączone ze sobą przestrzenie robocze: przestrzeń A (A), przestrzeń B (B), przestrzeń C (C), przy czym:-przestrzeń A (A): pobrania próbki, jest oddzielona korzystnie hermetycznie śluzami (Ś) od dalszej części kontenera to jest przestrzeni B (B) oraz od otoczenia kontenera (K); a przestrzeń A (A) wykorzystywana jest do identyfikacji pacjenta oraz indywidualnego, pobrania próbki patogenu - wirusa i/lub bakterii, -przestrzeń B (B): zautomatyzowanej diagnozy-weryfikacji pobranej próbki; jest oddzielona z obu stron korzystnie hermetycznie śluzami od sąsiadujących przestrzeni —to jest przestrzeni A (A) i przestrzeni C (C); a przestrzeń B (B) wykorzystywana jest do realizacji badań nad próbką oraz zarejestrowania wyników (PBL3) pacjenta, a po zakończeniu badania — korzystnie do utylizacji materiału korzystnie poprzez jego spalenie w odpowiednim urządzeniu; przestrzeń C (C): serwisowo-magazynowa oraz zawierająca system informatyczny (S) oraz systemy pomocnicze (P), w tym system odbioru popiołu powstałego w procesie utylizacji materiału badanego; przy tym tak zbudowane laboratorium umożliwia bezpieczne epidemiologicznie i samodzielne pobranie próbki przez pacjenta oraz automatyczne przejęcie próbki od pacjenta w tym jej dalsze umieszczenie w urządzeniu do analizy bez udziału osób trzecich to jest za pomocą wyłącznie pacjenta i/lub laboratoryjnego robota (R), następnie w pełni do automatycznej diagnozy, przy tym uzyskane wyniki z badania próbki przysłane są za pomocą systemu informatycznego (S), korzystnie w czasie rzeczywistym do służb sanitarno-epidemiologicznych oraz wysyłane są do osoby badanej — pacjenta wraz z instrukcją sposobu dalszego postępowania, korzystnie za pomocą wiadomości SMS ( ang. „short message service”) i/lub e-maila; przy tym w każdej z przestrzeni A, B, C korzystnie umieszcza się urządzenia dezynfekujące, korzystnie takie jak ozonator i/lub lampy na promieniowanie UVC, a przestrzenie A, B są dezynfekowane automatycznie po każdym użyciu i/lub pacjencie, przy czym laboratorium posiada całkowicie niezależne oraz zintegrowane systemy umożliwiające uniezależnienie się od jakichkolwiek źródeł zewnętrznych to jest zasilania w energię elektryczną, wody, kanalizacji oraz łączności.The subject of the application is the RoMoLab mobile automated laboratory, especially for testing for COVID-19, using a container, power generator, monitor, photovoltaic panels, and medical equipment, characterized by the fact that the laboratory is built on the basis of a container, preferably a 40-foot container, the container (K ) is divided inside into at least three interconnected working spaces: space A (A), space B (B), space C (C), where: - space A (A): sampling, is preferably hermetically separated by locks (M) from the distal part of the container, that is space B (B) and from the vicinity of the container (K); and space A (A) is used for patient and individual identification, sampling of pathogen - virus and / or bacteria, - space B (B): automated diagnosis-verification of the collected sample; it is separated on both sides, preferably hermetically, by airlocks from adjacent spaces - i.e. spaces A (A) and spaces C (C); and space B (B) is used to carry out the research on the sample and to record the results (PBL3) of the patient, and after completion of the test - preferably to dispose of the material, preferably by burning it in a suitable device; space C (C): service and storage space and space containing the IT system (S) and auxiliary systems (P), including the ash collection system generated in the process of utilization of the tested material; At the same time, a laboratory constructed in this way enables epidemiologically safe and independent sampling by the patient and automatic collection of the sample from the patient, including its further placement in the analysis device without the participation of third parties, i.e. using only the patient and / or the laboratory robot (R), then in fully for automatic diagnosis, while the obtained results from the examination of the samples are sent via the information system (S), preferably in real time to the sanitary and epidemiological services and they are sent to the examined person - the patient with instructions on how to proceed, preferably by message SMS (short message service) and / or e-mail; in this case, in each of the spaces A, B, C disinfecting devices are preferably placed, preferably such as an ozonator and / or UVC lamps, and the spaces A, B are disinfected automatically after each use and / or patient, the laboratory having a complete independent and integrated systems enabling independence from any external sources, i.e. electricity, water, sewage and communication.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL433887A PL433887A1 (en) | 2020-05-11 | 2020-05-11 | RoMoLab mobile automated laboratory, in particular for testing for COVID-I9 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL433887A PL433887A1 (en) | 2020-05-11 | 2020-05-11 | RoMoLab mobile automated laboratory, in particular for testing for COVID-I9 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL433887A1 true PL433887A1 (en) | 2021-11-15 |
Family
ID=78595467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL433887A PL433887A1 (en) | 2020-05-11 | 2020-05-11 | RoMoLab mobile automated laboratory, in particular for testing for COVID-I9 |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL433887A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL440796A1 (en) * | 2022-03-30 | 2023-10-02 | Politechnika Gdanska | System for the illumination and inactivation of micro-organisms and their spores in rooms, especially the inactivation of viruses, bacteria and fungi |
-
2020
- 2020-05-11 PL PL433887A patent/PL433887A1/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL440796A1 (en) * | 2022-03-30 | 2023-10-02 | Politechnika Gdanska | System for the illumination and inactivation of micro-organisms and their spores in rooms, especially the inactivation of viruses, bacteria and fungi |
| PL246647B1 (en) * | 2022-03-30 | 2025-02-17 | Politechnika Gdanska | A system for illuminating and deactivating microorganisms and their spores in rooms, especially for inactivating viruses, bacteria and fungi. |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Capoor et al. | Current perspectives of biomedical waste management in context of COVID-19” | |
| Clarke et al. | Polymerase chain reaction can detect bacterial DNA in aseptically loose total hip arthroplasties | |
| Litvinov et al. | Endemic human blastomycosis in Quebec, Canada, 1988–2011 | |
| EP4159176A1 (en) | Examination system | |
| Lomas et al. | Effects of a peracetic acid disinfection protocol on the biocompatibility and biomechanical properties of human patellar tendon allografts | |
| PL433887A1 (en) | RoMoLab mobile automated laboratory, in particular for testing for COVID-I9 | |
| Keswani et al. | Skin banking at a regional burns centre—The way forward | |
| Stauning et al. | Genetic relationship between bacteria isolated from intraoperative air samples and surgical site infections at a major teaching hospital in Ghana | |
| Kučera et al. | Was He Murdered or Was He Not?—Part II: Multi‐Elemental Analyses of Hair and Bone Samples from Tycho Brahe and Histopathology of His Bones | |
| Audette-Stuart et al. | Adaptive response in frogs chronically exposed to low doses of ionizing radiation in the environment | |
| Rutty et al. | DNA contamination of mortuary instruments and work surfaces: a significant problem in forensic practice? | |
| DE102019200595B3 (en) | DEVICE WITH PROTECTION LEVEL AREA FOR DIRECTLY OR INDIRECTLY DETECTING ONE OR MORE BIOSE SUBSTANCES OR ONE OR MORE SUBSTANCES IN AT LEAST ONE SAMPLE THAT MAY CONTAIN A BIOS SUBSTANCE | |
| Rehse | Biomedical applications of LIBS | |
| Shetty et al. | ABO blood grouping from tooth material | |
| Singh et al. | Rapid identification and drug susceptibility testing of Mycobacterium tuberculosis: standard operating procedure for non-commercial assays: part 1: microscopic observation drug susceptibility assay v2. 4.12 | |
| Shambhu et al. | A study on the effect on surface detail reproduction of alginate impressions disinfected with sodium hypochlorite and ultraviolet light—an in vitro study | |
| Oltjen et al. | SARS‐CoV‐2 delta variant in African lions (Panthera leo) and humans at Utah's Hogle Zoo, USA, 2021–22 | |
| Bloom | Xenotransplantation—Federal regulatory considerations | |
| Yazdi et al. | Effect of three different sterilizing solutions on the contaminated bone: an experimental study in the rabbit | |
| Ahmadu et al. | Phenotypic characterization of mycobacteria isolates from tuberculosis patients in Kaduna State, Nigeria | |
| Kouriba et al. | Installing biosafety level 3 containment laboratories in low-and middle-income countries: challenges and prospects from Mali's experience | |
| CN201591856U (en) | Medical file sterilizing cabinet | |
| Pawar et al. | Cytogenetic analysis of human lymphocytes of fluorosis-affected men from the endemic fluorosis region in Nalgonda district of Andhra Pradesh, India | |
| Singh et al. | Rapid identification and drug susceptibility testing of Mycobacterium tuberculosis: standard operating procedure for non-commercial assays: part 2: nitrate reductase assay v1. 3.12 | |
| Lemons | Retrieval and analysis of explanted and in situ implants including bone grafts |